Eurofarma Innovation and Growth Strategy
10
10
INTERNATIONALIZATION STRATEGY
Continuous M&As in LatAm
eurofarma
Beginning of the
LatAm expansion
Acquisitions of 2 leading
regional pharmas
52% LatAm coverage
Further expansion
to new markets and
consolidation process
64% LatAm coverage
Expansion to Central America
100% LatAm coverage
Entrance in the 2nd
lagest market
100% LatAm coverage
2009
Q
QUESADA FARMACEUTICA
Acquisition of
regional pharma
2010
2012-2013
Facility from
MERCK
INVENTING FOR LIFE
GAUTIER
Farmaindustria and
A
Volta Laboratorios
25th largest
local pharma
REFASA
2019
2020-2021
SSTEIN CORP.
Prescription drug line with
+90 products
medipharm
LABORATORIO
From 45th to 21st in Chilean market
Successful acquisitions in Mexico
Takeda
12 licensed
brands
US$161mm
acquisition
Lilly
#1 prescribed
antibiotic
US$30mm
acquisition
Product acquisition from
Craveri Lab
BUXTON
Focus on biological products
Product acquisition from
Bayer LabView entire presentation